SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-13-000548
Filing Date
2013-03-28
Accepted
2013-03-28 17:03:45
Documents
15
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 fpmi10kdec312012.htm 10-K 1625483
2 ex23-1.htm EX-23.1 2527
3 ex23-2.htm EX-23.2 3328
4 ex31-1.htm EX-31.1 9300
5 ex31-2.htm EX-31.2 9519
6 ex32-1.htm EX-32.1 4737
7 ex32-2.htm EX-32.2 4796
8 mmheader.jpg GRAPHIC 5980
9 mmsig.jpg GRAPHIC 4737
  Complete submission text file 0001415889-13-000548.txt   5315355

Data Files

Seq Description Document Type Size
10 fpmi-20121231.xml EX-101.INS 467027
11 fpmi-20121231.xsd EX-101.SCH 66125
12 fpmi-20121231_pre.xml EX-101.PRE 254007
13 fpmi-20121231_lab.xml EX-101.LAB 399643
14 fpmi-20121231_def.xml EX-101.DEF 121211
15 fpmi-20121231_cal.xml EX-101.CAL 45561
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-147193 | Film No.: 13724802
SIC: 2835 In Vitro & In Vivo Diagnostic Substances